The phage MuA transposase market is projected to grow from USD 321.1 billion in 2025 to USD 726.0 billion by 2035, at a CAGR of 8.5%. Standard Active Enzyme will dominate with a 36.6% market share, while biopharmaceuticals will lead the application segment with a 48.3% share.